We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Masimo's (MASI) Q1 healthcare revenues reflect strong sensor orders, which were completely offset by lower capital equipment purchases. Sensor production in Malaysia is likely to improve Healthcare gross margin.
Fresenius Medical's (FMS) first-quarter revenues suffer due to unfavorable currency movement. However, the company's transformational plans continue to benefit its operating income.
Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and PNTG are well-poised to gain.
Despite strength in Revio and Onso platforms, an increasing number of customers delaying instrument purchases is likely to have dampened PacBio's (PACB) top line in the first quarter.
Strong demand for Integra's (IART) diverse portfolio of leading brands and continued successful market adoption of CereLink contributes to its revenues.
Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and gross margin expansion amid JNJ entering into a definitive agreement to acquire the company.
GE HealthCare's (GEHC) new SIGNA MAGNUS can delve deep into the brain's microstructure, microvasculature and function, providing researchers with a clearer picture of neurological diseases and disorders.
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how INSP, MCK, FMS, NVRO and INGN are placed ahead of their earnings releases.
McKesson's (MCK) fourth-quarter fiscal 2024 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.
Surmodics (SRDX) fiscal second-quarter results showcase growth in the medical device segment. The bottom line improves and beats the Zacks Consensus Estimate.
medical-devices: Archive
Inspire Medical (INSP) Q1 Earnings Beat, Gross Margin Up
by Zacks Equity Research
Inspire Medical's (INSP) both geographic segments witness strong revenue growth in the first quarter.
BSXNegative Net Change ALGNNegative Net Change RMDNegative Net Change INSPNegative Net Change
earnings medical medical-devices
Masimo (MASI) Q1 Earnings Beat Estimates, '24 EPS View Up
by Zacks Equity Research
Masimo's (MASI) Q1 healthcare revenues reflect strong sensor orders, which were completely offset by lower capital equipment purchases. Sensor production in Malaysia is likely to improve Healthcare gross margin.
BSXNegative Net Change ECLNegative Net Change ALGNNegative Net Change MASINegative Net Change
earnings medical medical-devices
Fresenius Medical (FMS) Q1 Earnings Beat, Operating Margin Up
by Zacks Equity Research
Fresenius Medical's (FMS) first-quarter revenues suffer due to unfavorable currency movement. However, the company's transformational plans continue to benefit its operating income.
BSXNegative Net Change ECLNegative Net Change ALGNNegative Net Change FMSPositive Net Change
earnings medical medical-devices
4 Stocks to Buy in a Thriving Outpatient Home Health Industry
by Debanjana Dey
Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and PNTG are well-poised to gain.
DVANegative Net Change EHCNegative Net Change PNTGPositive Net Change OPCHNegative Net Change
medical medical-devices
3 Stocks Backed by High Efficiency to Strengthen Your Portfolio
by Santanu Roy
Invest in companies like Option Care Health (OPCH), ReWalk Robotics Ltd. (LFWD) and Garmin (GRMN), as they boast higher efficiency levels.
GRMNNegative Net Change OPCHNegative Net Change LFWDPositive Net Change
communications medical medical-devices
Veracyte (VCYT) Reports Narrower Q1 Loss, Raises '24 Sales View
by Zacks Equity Research
Veracyte's (VCYT) first-quarter 2024 performance reflects the strength of its testing business.
RMDNegative Net Change VCYTNegative Net Change MEDPNegative Net Change EHCNegative Net Change
earnings medical medical-devices
Globus Medical (GMED) Q1 Earnings Top Estimates, Margins Fall
by Zacks Equity Research
Globus Medical (GMED) delivers massive sales and earnings growth in the first quarter of 2024.
RMDNegative Net Change GMEDPositive Net Change MEDPNegative Net Change EHCNegative Net Change
earnings medical medical-devices
Soft Instrument Orders Likely to Hurt PacBio's (PACB) Q1 Earnings
by Zacks Equity Research
Despite strength in Revio and Onso platforms, an increasing number of customers delaying instrument purchases is likely to have dampened PacBio's (PACB) top line in the first quarter.
ALCNegative Net Change PACBNegative Net Change IGMSNegative Net Change ERASNegative Net Change
earnings medical medical-devices
Integra's (IART) Q1 Earnings Match Estimates, Margins Down
by Zacks Equity Research
Strong demand for Integra's (IART) diverse portfolio of leading brands and continued successful market adoption of CereLink contributes to its revenues.
BSXNegative Net Change ALGNNegative Net Change RMDNegative Net Change IARTNegative Net Change
earnings medical medical-devices
Shockwave Medical (SWAV) Q1 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and gross margin expansion amid JNJ entering into a definitive agreement to acquire the company.
BSXNegative Net Change ECLNegative Net Change ALGNNegative Net Change SWAVNo Net Change
earnings medical medical-devices
Henry Schein (HSIC) Tops Q1 Earnings, Lowers '24 Sales View
by Zacks Equity Research
Henry Schein's (HSIC) first-quarter performance reflects a strong recovery from last year's cyber incident.
RMDNegative Net Change HSICPositive Net Change MEDPNegative Net Change EHCNegative Net Change
earnings medical medical-devices
GE HealthCare (GEHC) Unveils Head-Only MR Scanner SIGNA MAGNUS
by Zacks Equity Research
GE HealthCare's (GEHC) new SIGNA MAGNUS can delve deep into the brain's microstructure, microvasculature and function, providing researchers with a clearer picture of neurological diseases and disorders.
BSXNegative Net Change ECLNegative Net Change ALGNNegative Net Change GEHCNegative Net Change
medical medical-devices
Don't Overlook These Top Medical Stocks as Q1 Earnings Approach
by Shaun Pruitt
Several top-rated Zacks Medical sector stocks are standing out ahead of their quarterly reports on Tuesday, May 7.
LGNDPositive Net Change PENNegative Net Change OSCRPositive Net Change
earnings investing medical medical-devices
PetIQ (PETQ) Gears Up to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
PetIQ's (PETQ) first-quarter results are likely to reflect growth in the Product and Services segments of the business.
ALCNegative Net Change BPMCNegative Net Change ADVMNegative Net Change PETQPositive Net Change
medical medical-devices
Will These 5 Medical Device Stocks Beat This Earnings Season?
by Zacks Equity Research
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how INSP, MCK, FMS, NVRO and INGN are placed ahead of their earnings releases.
MCKPositive Net Change FMSPositive Net Change INGNPositive Net Change NVRONegative Net Change INSPNegative Net Change
earnings medical medical-devices
Should SNDL (SNDL) be in Your Portfolio Ahead of Q1 Earnings?
by Riya Anand
SNDL's (SNDL) first-quarter performance is expected to benefit from reduced cost expenses and expansion into the liquor retail segment.
ALCNegative Net Change GRTSNo Net Change SNDLNegative Net Change ERASNegative Net Change
earnings medical medical-devices
McKesson (MCK) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
McKesson's (MCK) fourth-quarter fiscal 2024 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.
MCKPositive Net Change ALCNegative Net Change FMSPositive Net Change RDNTNegative Net Change
medical medical-devices
Omnicell (OMCL) Q1 Earnings Top Estimates, Revenues Down Y/Y
by Zacks Equity Research
Omnicell (OMCL) outpaces expectations in the first quarter of 2024 in a challenging customer environment.
OMINegative Net Change OMCLNegative Net Change MEDPNegative Net Change EHCNegative Net Change
earnings medical medical-devices
Avanos (AVNS) Q1 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
Avanos' (AVNS) first-quarter results show strong bottom-line improvement along with decent growth in segmental revenues.
BSXNegative Net Change ECLNegative Net Change ALGNNegative Net Change AVNSPositive Net Change
earnings medical medical-devices
Surmodics (SRDX) Q2 Earnings Top Estimates, '24 View Up
by Zacks Equity Research
Surmodics (SRDX) fiscal second-quarter results showcase growth in the medical device segment. The bottom line improves and beats the Zacks Consensus Estimate.
BSXNegative Net Change ECLNegative Net Change ALGNNegative Net Change SRDXNegative Net Change
earnings medical medical-devices
Hologic's (HOLX) Q2 Earnings Beat Estimates, 2024 View Up
by Zacks Equity Research
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
BSXNegative Net Change ALGNNegative Net Change RMDNegative Net Change HOLXNegative Net Change
earnings medical medical-devices
Lantheus (LNTH) Q1 Earnings Surpass Estimates, Gross Margin Up
by Zacks Equity Research
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.
BSXNegative Net Change ALGNNegative Net Change RMDNegative Net Change LNTHNegative Net Change
earnings medical medical-devices
DaVita (DVA) Q1 Earnings & Revenues Top Estimates, Margins Up
by Zacks Equity Research
DaVita's (DVA) robust segmental revenues drive its first-quarter performance.
BSXNegative Net Change DVANegative Net Change ALGNNegative Net Change RMDNegative Net Change
earnings medical medical-devices
Bruker (BRKR) Q1 Earnings Surpass Estimates, Margins Decline
by Zacks Equity Research
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.
BSXNegative Net Change ALGNNegative Net Change RMDNegative Net Change BRKRNegative Net Change
earnings medical medical-devices
GE Healthcare's (GEHC) Revolution RT to Aid Cancer Treatment
by Zacks Equity Research
GE Healthcare (GEHC) unveils Revolution RT, along with other upgrades, from its portfolio during the ESTRO 2024 Congress.
BSXNegative Net Change ECLNegative Net Change ALGNNegative Net Change GEHCNegative Net Change
artificial-intelligence medical-devices messenger-rna oncology-screening